Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05430555
Title A Phase 1/2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/Metastatic MAGE-A1+ Solid Tumors (IMAG1NE)
Acronym IMAG1NE
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors T-knife GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | GBR | ESP | DEU | BEL


No variant requirements are available.